Abstract
Vasodilator MPI is used for pre-liver transplant risk assessment. Liver failure is associated with significant splanchnic and peripheral vasodilation, questioning test accuracy. We sought to assess the vasodilatory response in patients with end-stage liver disease undergoing MPI with vasodilator
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
